Zobrazeno 1 - 10
of 1 720
pro vyhledávání: '"Erkrankungen"'
Autor:
Maria Palombini, Director, Healthcare and Life Sciences Practice, IEEE SA, Prof. Dr. Joachim L. Schultze, Director Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE); Director, Genomics & Immunoregulation, LIMES-Institute, University of Bonn Germany, Krishnaprasad Shastry, Director, Distinguished Technologist, Hewlett Packard Enterprise (HPE), Vikram Shetty, Medical Director, Singapore and Asia Area Lung Cancer Lead, AstraZeneca
Publikováno v:
Blockchain in Healthcare Today (2022)
Swarm learning opens new opportunities for collaboration and innovation in clinical research where all members of the swarm have equal rights. Only algorithms and parameters are shared – with no central authority. Swarm creates many new opportuniti
Externí odkaz:
https://doaj.org/article/a4897f845ffe41028ccc856cbd78738f
Autor:
Susanne Nettesheim, Stefan Kölker, Daniela Karall, Johannes Häberle, Roland Posset, Georg F. Hoffmann, Beate Heinrich, Florian Gleich, Sven F. Garbade, On behalf of Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen (APS); European registry and network for Intoxication type Metabolic Diseases (E-IMD); Erhebungseinheit für Seltene Pädiatrische Erkrankungen in Deutschland (ESPED); Austrian Metabolic Group; Swiss Paediatric Surveillance Unit (SPSU)
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 12, Iss 1, Pp 1-8 (2017)
Abstract Background Urea cycle disorders (UCDs) are a group of rare inherited metabolic disorders. Affected individuals often present with hyperammonemic encephalopathy (HE) and have an increased risk of severe neurologic disease and early death. The
Externí odkaz:
https://doaj.org/article/23370ecb154343929b185a6fd1033613
Autor:
null His, null Temkin, W. Fischer, null Jonas, null Oberniedermayr, null Eisner-Behrend, null Koenigsfeld, null Schmitz, null Nonnenbruch, null Oppenheimer, null Kleinschmidt, null Weigert, null Eckstein, null v. Jaschke, null Jacobsohn, null Schumacher, null Gottschalk, Erich Langer, null Buschke, null Finkenrath, null Halberstaedter, B. Valentin, null Valentin, null Simon, null Herzfeld, null Cohn, null Mendel, null Friedemann, null Lipschitz, null Goldstein, null Erkrankungen, null Wohlwill, null Riebeling
Publikováno v:
Klinische Wochenschrift. 9:1513-1519
Autor:
His, Temkin, Fischer, W., Jonas, Oberniedermayr, Eisner-Behrend, Koenigsfeld, Schmitz, Nonnenbruch, Oppenheimer, Kleinschmidt, Weigert, Eckstein, Jaschke, v., Jacobsohn, Schumacher, Gottschalk, Langer, Erich, Buschke, Finkenrath, Halberstaedter, Valentin, B., Valentin, Simon, Herzfeld, Cohn, Mendel, Friedemann, Lipschitz, Goldstein, Erkrankungen, Wohlwill, Riebeling
Publikováno v:
Journal of Molecular Medicine; August 1930, Vol. 9 Issue: 32 p1513-1519, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael Schön, Pablo Lapunzina, Julián Nevado, Teresa Mattina, Cecilia Gunnarsson, Kinga Hadzsiev, Chiara Verpelli, Thomas Bourgeron, Sarah Jesse, Conny M.A. van Ravenswaaij-Arts, Raoul C. Hennekam
Publikováno v:
European journal of medical genetics, 66(7):104754. Elsevier Masson SAS
European Journal of Medical Genetics
European Journal of Medical Genetics, 2023, 66 (7), pp.104754. ⟨10.1016/j.ejmg.2023.104754⟩
European Journal of Medical Genetics
European Journal of Medical Genetics, 2023, 66 (7), pp.104754. ⟨10.1016/j.ejmg.2023.104754⟩
International audience; Phelan-McDermid syndrome (PMS) is an infrequently described syndrome that presents with a disturbed development, neurological and psychiatric characteristics, and sometimes other comorbidities. As part of the development of Eu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f86e321faa2747a743e5105b4d414b
https://pure.amc.nl/en/publications/definition-and-clinical-variability-of-shank3related-phelanmcdermid-syndrome(b728fe2b-83e2-49d7-b696-846b60d89de8).html
https://pure.amc.nl/en/publications/definition-and-clinical-variability-of-shank3related-phelanmcdermid-syndrome(b728fe2b-83e2-49d7-b696-846b60d89de8).html
Publikováno v:
European Journal of Medical Genetics
European Journal of Medical Genetics, 2023, 66 (6), pp.104746. ⟨10.1016/j.ejmg.2023.104746⟩
European Journal of Medical Genetics, 2023, 66 (6), pp.104746. ⟨10.1016/j.ejmg.2023.104746⟩
International audience; Phelan-McDermid syndrome (PMS) is a 22q13.3 deletion syndrome that presents with a disturbed development, neurological and psychiatric characteristics, and sometimes other comorbidities like seizures. The epilepsy manifests it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec439b4d896c22f945bf305b105de53
https://hal-pasteur.archives-ouvertes.fr/pasteur-04145555/file/1-s2.0-S1769721223000526-main.pdf
https://hal-pasteur.archives-ouvertes.fr/pasteur-04145555/file/1-s2.0-S1769721223000526-main.pdf
Autor:
Dominique Endres, Thomas A. Pollak, Karl Bechter, Dominik Denzel, Karoline Pitsch, Kathrin Nickel, Kimon Runge, Benjamin Pankratz, David Klatzmann, Ryad Tamouza, Luc Mallet, Marion Leboyer, Harald Prüss, Ulrich Voderholzer, Janet L. Cunningham, ECNP Network Immuno-NeuroPsychiatry, Katharina Domschke, Ludger Tebartz van Elst, Miriam A. Schiele
Publikováno v:
Translational Psychiatry
Translational Psychiatry, 2022, 12 (1), pp.5. ⟨10.1038/s41398-021-01700-4⟩
Translational Psychiatry, Nature Pub. Group, 2022, 12 (1), pp.5. ⟨10.1038/s41398-021-01700-4⟩
Translational Psychiatry, Vol 12, Iss 1, Pp 1-14 (2022)
Translational Psychiatry 12(1), 5 (2022). doi:10.1038/s41398-021-01700-4
Translational Psychiatry, 2022, 12 (1), pp.5. ⟨10.1038/s41398-021-01700-4⟩
Translational Psychiatry, Nature Pub. Group, 2022, 12 (1), pp.5. ⟨10.1038/s41398-021-01700-4⟩
Translational Psychiatry, Vol 12, Iss 1, Pp 1-14 (2022)
Translational Psychiatry 12(1), 5 (2022). doi:10.1038/s41398-021-01700-4
Obsessive-compulsive disorder (OCD) is a highly disabling mental illness that can be divided into frequent primary and rarer organic secondary forms. Its association with secondary autoimmune triggers was introduced through the discovery of Pediatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d00925513be1fea7f35468c3030db6f
https://doi.org/10.1038/s41398-021-01700-4
https://doi.org/10.1038/s41398-021-01700-4
Autor:
Simon Witzel, Felix Frauhammer, Petra Steinacker, David Devos, Pierre-François Pradat, Vincent Meininger, Steffen Halbgebauer, Patrick Oeckl, Joachim Schuster, Simon Anders, Johannes Dorst, Markus Otto, Albert C. Ludolph
Publikováno v:
Translational Neurodegeneration
Translational Neurodegeneration, 2021, 10 (1), ⟨10.1186/s40035-021-00257-y⟩
Translational Neurodegeneration, [London] : BioMed Central, 2012-, 2021, 10 (1), ⟨10.1186/s40035-021-00257-y⟩
Translational neurodegeneration 10(1), 31 (2021). doi:10.1186/s40035-021-00257-y
Translational Neurodegeneration, Vol 10, Iss 1, Pp 1-12 (2021)
Translational Neurodegeneration, 2021, 10 (1), ⟨10.1186/s40035-021-00257-y⟩
Translational Neurodegeneration, [London] : BioMed Central, 2012-, 2021, 10 (1), ⟨10.1186/s40035-021-00257-y⟩
Translational neurodegeneration 10(1), 31 (2021). doi:10.1186/s40035-021-00257-y
Translational Neurodegeneration, Vol 10, Iss 1, Pp 1-12 (2021)
Background Interventional trials in amyotrophic lateral sclerosis (ALS) suffer from the heterogeneity of the disease as it considerably reduces statistical power. We asked if blood neurofilament light chains (NfL) could be used to anticipate disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226ac4f7462fbc3e7facd78a0e0e0e13
https://hal.sorbonne-universite.fr/hal-03354037/document
https://hal.sorbonne-universite.fr/hal-03354037/document
Autor:
Scekic-Zahirovic, Jelena, Sanjuan-Ruiz, Inmaculada, Kan, Vanessa, Megat, Salim, De Rossi, Pierre, Dieterlé, Stéphane, Cassel, Raphaelle, Jamet, Marguerite, Kessler, Pascal, Wiesner, Diana, Tzeplaeff, Laura, Demais, Valérie, Sahadevan, Sonu, Hembach, Katharina M, Muller, Hans-Peter, Picchiarelli, Gina, Mishra, Nibha, Antonucci, Stefano, Dirrig-Grosch, Sylvie, Kassubek, Jan, Rasche, Volker, Ludolph, Albert, Boutillier, Anne-Laurence, Roselli, Francesco, Polymenidou, Magdalini, Lagier-Tourenne, Clotilde, Liebscher, Sabine, Dupuis, Luc
Publikováno v:
Nature Communications
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.3028. ⟨10.1038/s41467-021-23187-9⟩
Nature Communications, Vol 12, Iss 1, Pp 1-19 (2021)
Nature Communications 12(1), 3028 (2021). doi:10.1038/s41467-021-23187-9
Nature Communications, Nature Publishing Group, 2021, 12 (1), ⟨10.1038/s41467-021-23187-9⟩
Nature Communications, 2021, 12 (1), ⟨10.1038/s41467-021-23187-9⟩
Nature Communications, 2021, 12 (1), pp.3028. ⟨10.1038/s41467-021-23187-9⟩
Nature Communications, Nature Publishing Group, 2021, 12 (1), pp.3028. ⟨10.1038/s41467-021-23187-9⟩
Nature Communications, Vol 12, Iss 1, Pp 1-19 (2021)
Nature Communications 12(1), 3028 (2021). doi:10.1038/s41467-021-23187-9
Nature Communications, Nature Publishing Group, 2021, 12 (1), ⟨10.1038/s41467-021-23187-9⟩
Nature Communications, 2021, 12 (1), ⟨10.1038/s41467-021-23187-9⟩
Nature Communications, 2021, 12 (1), pp.3028. ⟨10.1038/s41467-021-23187-9⟩
Gene mutations causing cytoplasmic mislocalization of the RNA-binding protein FUS lead to severe forms of amyotrophic lateral sclerosis (ALS). Cytoplasmic accumulation of FUS is also observed in other diseases, with unknown consequences. Here, we sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::c8536f94d17455134cebd44e2729e13b
https://www.hal.inserm.fr/inserm-03376335
https://www.hal.inserm.fr/inserm-03376335